News
Higher ADHD risk seen in children with migraine
BOSTON – Link with attention problem seen with migraine, but not tension-type headaches.
News
As designer drugs multiply, toxicologists spring into action
SAN DIEGO – New designer drugs are constantly hitting the market. They’re often especially appealing – and especially risky – because routine drug...
News
Gene therapy for spinal muscular atrophy shows promise in early study
BOSTON – Early data show remarkable results for a gene therapy with few adverse events, in a phase I study.
News
Red flags for type 2 diabetes seen 25 years before diagnosis
SAN DIEGO – A Swedish cohort study associated lab values with a greater likelihood of a type 2 diabetes diagnosis 25 years later.
News
TB meningitis cases in U.S. are fewer but more complicated
BOSTON – Seizures and strokes have risen in hospitalized TB meningitis patients.
News
App allows monitoring of drug effects in Parkinson’s
BOSTON – Patients can test physical, mental skills every few hours.
News
Promising phase II results for Rytary reformulation for Parkinson’s
BOSTON – Investigational carbidopa-levodopa drug improved “on” time.
News
Dermatologist calls for paradigm shift on treating ocular rosacea
A new approach for treating ocular rosacea is on its way.
News
Oral insulin matches glargine in phase II trial
But Novo Nordisk has stopped drug development.
News
Arab Americans reluctant to seek depression care from psychiatrists
SAN DIEGO – New study results support focus on primary care for meeting the mental health needs of this population.
News
Apomorphine pump dramatically decreases ‘off’ time in Parkinson’s
BOSTON – The degree of improvement has proved to be clinically relevant.
News
Most veterans with schizophrenia or bipolar I report suicide attempts
New study supports “continuous monitoring for suicidality” among veterans.
News
Consistent weight benefits seen in empagliflozin use
Measures improved across age, gender, and degree of obesity.
News
Vets with TBIs are more likely to develop Parkinson’s
BOSTON – The effects of head injuries don’t disappear with the symptoms.
News
REMOVAL: Metformin may reduce cardiac risk in type 1 diabetes but doesn’t improve glucose control
SAN DIEGO – With disappointing results, metformin may not be as useful as previously thought.